Literature DB >> 30159354

A comment on medication adherence in geriatric patients: A reply to Abarazi et al. (2017).

Saurav Basu1.   

Abstract

Entities:  

Year:  2018        PMID: 30159354      PMCID: PMC6089038          DOI: 10.4103/jehp.jehp_4_18

Source DB:  PubMed          Journal:  J Educ Health Promot        ISSN: 2277-9531


× No keyword cloud information.
Sir, The article by Abazari et al. (2017) reports the adherence to drug therapy in older geriatric populations in Iran.[1] The study generates important evidence regarding medication adherence in the geriatric population which is particularly at risk of developing noncommunicable diseases However, there is a methodological concern regarding the study which is discussed below. The geriatric population could suffer from several disease conditions such as diabetes, hypertension, chronic obstructive pulmonary disease, lipid disorders, and osteoporosis which require drug administration for durations extending till the end of life. Several comorbid conditions are often found in geriatric patients. The Abarazi (2017) study evaluated self-reported medication adherence jointly for all these distinct medical conditions although the 8-item Morisky Medication Adherence Scale-8 is validated only for individual disease conditions such as hypertension and diabetes.[23] The Abarazi (2017) study, therefore, is unable to distinguish between the extent of medication adherence in a condition like diabetes from that of another like hypertension. Furthermore, the authors could have also explored the association of comorbidity with medication adherence. This is because comorbidity, like the presence of both diabetes and hypertension in the same subject, can impede medication adherence due to factors like increasing regimen complexity.[4] Furthermore, the high pill burden could deter adherence as patients may perceive the risk of adverse effects from taking too many medications.[5] Patient adherence to different disease conditions can also be influenced by their perceived susceptibility to the disease complications which can vary for different diseases as per the Health Belief Model.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  5 in total

1.  The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version.

Authors:  Harith Kh Al-Qazaz; Mohamed A Hassali; Asrul A Shafie; Syed A Sulaiman; Shameni Sundram; Donald E Morisky
Journal:  Diabetes Res Clin Pract       Date:  2010-09-15       Impact factor: 5.602

2.  Barriers to medication adherence in poorly controlled diabetes mellitus.

Authors:  Peggy Soule Odegard; Shelly L Gray
Journal:  Diabetes Educ       Date:  2008 Jul-Aug       Impact factor: 2.140

3.  How much elderly people of Isfahan are adherent to their drug therapy regimens?

Authors:  Parvaneh Abazari; Tayebe Arab Jafari; Ali Mohammad Sabzghabaee
Journal:  J Educ Health Promot       Date:  2017-04-19

4.  Predictive validity of a medication adherence measure in an outpatient setting.

Authors:  Donald E Morisky; Alfonso Ang; Marie Krousel-Wood; Harry J Ward
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 2.885

5.  Control of Hypertension among Diabetic Patients in a Referral Hospital in Tanzania: A Cross-Sectional Study.

Authors:  Semvua B Kilonzo; Daniel W Gunda; Fatma A Bakshi; Fredrick Kalokola; Henry A Mayala; Hollo Dadi
Journal:  Ethiop J Health Sci       Date:  2017-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.